?

Strain heterogeneity**: How do distinct TDP-43 conformational strains influence clinical phenotypes?

active
open question Created: 2026-04-25T20:29:31 By: backfill_open_questions Quality: 50% ✓ SciDEX ID: open_question-daa5cea2-144d-432b-8d21-3a
Open Question open Wiki: mechanisms-als-tdp43-pathology
Strain heterogeneity**: How do distinct TDP-43 conformational strains influence clinical phenotypes?
Importance Elo
1500
Field Rank
Rank #1140 in mechanisms
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page mechanisms-als-tdp43-pathology
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
RNA-Binding Competition Therapy for TDP-43 Cross-Seeding
candidate answer · hypothesis · 78%
APOE Isoform Expression Across Glial Subtypes
bears on question · hypothesis · 45%
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
RNA-Binding Competition Therapy for TDP-43 Cross-Seeding
hypothesis | candidate_answer
APOE Isoform Expression Across Glial Subtypes
hypothesis | bears_on_question
Related Entities
mechanisms
Metadata
statusopen
_origin{'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:29:31.424908'}
field_tagmechanisms
source_idmechanisms-als-tdp43-pathology
sub_fieldals-tdp43-pathology
source_kindwiki
question_hash4062750b5750caf4cc99b9e620b6ddd7d9bce7a9910f6ef511ca677f2d51a802
question_textStrain heterogeneity**: How do distinct TDP-43 conformational strains influence clinical phenotypes?
importance_elo1500
_schema_version1
evidence_summaryExtracted from wiki page mechanisms-als-tdp43-pathology
evidence_xref_at2026-04-27T14:11:28.071214+00:00
tractability_score0.5
potential_impact_score0.5
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
3
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.